Revolution Medicines, Inc. Deferred Taxes remained flat by 0.0% to $2.35M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.35M to $2.35M. Over 5 years (FY 2020 to FY 2025), Deferred Taxes shows a downward trend with a -20.6% CAGR.
An increase suggests the company is deferring tax payments, which can improve current cash flow, while a decrease indicates the settlement of these deferred obligations.
This represents the amount of income taxes payable in future periods as a result of temporary differences between the ca...
Standard across all industries; levels are driven by capital expenditure cycles and depreciation methods.
other_deferred_income_tax_liabilities_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.44M | $7.44M | $7.44M | $7.44M | $7.44M | $7.15M | $7.03M | $7.03M | $7.03M | $3.16M | $3.12M | $3.12M | $3.12M | $3.12M | $2.35M | $2.35M | $2.35M | $2.35M | $2.35M | $2.35M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | -4.0% | -1.7% | +0.0% | +0.0% | -55.0% | -1.4% | +0.0% | +0.0% | +0.0% | -24.5% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | -4.0% | -5.6% | -5.6% | -5.6% | -55.8% | -55.7% | -55.7% | -55.7% | -1.4% | -24.5% | -24.5% | -24.5% | -24.5% | +0.0% | +0.0% |